News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
171 Results
Type
Article (5)
Company Profile (1)
Press Release (165)
Section
Business (65)
Deals (5)
Drug Delivery (1)
Drug Development (44)
News (110)
Policy (6)
Tag
Alliances (19)
Biotechnology (1)
CAR-T (2)
Cell therapy (3)
Clinical research (36)
Collaboration (1)
Earnings (27)
Events (20)
FDA (1)
Funding (1)
Government (2)
IPO (1)
Manufacturing (3)
Mergers & acquisitions (4)
People (19)
Phase 2 (14)
Phase 3 (23)
Pipeline (1)
Postmarket research (3)
Preclinical (4)
Regulatory (5)
Series A (1)
Startups (2)
Vaccines (3)
Date
Last 30 days (1)
Last 365 days (6)
2026 (1)
2025 (5)
2024 (10)
2023 (7)
2022 (7)
2021 (5)
2020 (2)
2019 (4)
2018 (9)
2017 (24)
2016 (24)
2015 (40)
2014 (16)
2013 (4)
2012 (6)
2011 (4)
2010 (1)
Location
Asia (3)
Australia (1)
California (1)
China (1)
Europe (15)
Nevada (1)
North Carolina (5)
Pennsylvania (1)
Southern California (1)
United States (7)
171 Results for "inceptor bio.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Inceptor Bio Announces First Patient Dosed in Clinical Trial of IB-T101 for Clear Cell Renal Cell Carcinoma (ccRCC) and $21M Series A2 Financing
February 25, 2025
·
3 min read
Press Releases
Inceptor Bio and GRIT Bio Announce Strategic Partnership to Advance IB-T101, a Next-Generation Solid Tumor CAR-T Utilizing the OUTLAST™ Platform
December 19, 2024
·
3 min read
Business
Inceptor Bio Appoints Matthias Schroff, PhD, as Chief Executive Officer
Inceptor Bio, a biotechnology company advancing cell therapies for difficult-to-treat cancers, announced the appointment of Dr. Matthias Schroff as CEO.
May 8, 2023
·
1 min read
Business
SPONSORED: Closing the Opportunity Gap--How Inceptor Bio Supports Women Leaders
Women are often at the forefront of innovation, making up nearly half of the life sciences industry despite a shrinking but persistent wage gap. Inceptor Bio is at the forefront of closing inequality.
March 8, 2023
·
2 min read
·
Lisa Munger
Inceptor Bio and Avectas Announce Collaboration to Improve Manufacturing of CAR-T Cell Therapies for the Treatment of Solid Tumors
Collaboration brings together Avectas’ breakthrough cell engineering technology and Inceptor Bio’s CAR-T platform
October 12, 2022
·
2 min read
Bio NC
Inceptor Bio Snags $37M for Three-Pronged Immuno-Oncology Platforms
Fueled by $37 million in Series A financing, N.C.-based Inceptor Bio is advancing three, next-generation approaches to immuno-oncology, including a CAR-T program that is expected to be in the clinic next year.
May 20, 2022
·
4 min read
·
Alex Keown
Business
Inceptor Bio Announces Strategic Collaboration with University of Minnesota to Develop Novel iPSC Platform for the Advancement of Next-Generation Allogeneic Cell Therapies
Inceptor Bio, a biotechnology company advancing cell therapies for difficult-to-treat cancers, today announced a collaboration with University of Minnesota.
June 30, 2022
·
2 min read
Bio NC
Inceptor Bio Announces $37 Million Series A Financing to Develop Cell Therapies for Difficult-to-Treat Cancers
Inceptor Bio, a biotechnology company advancing cell therapies for difficult-to-treat cancers, today announced the closing of a $37 million Series A financing led by Kineticos Ventures.
May 19, 2022
·
3 min read
Deals
Inceptor Bio Announces Agreement to Acquire Gainesville, FL GMP Facility And Transfer Operating Team From Arranta Bio To Accelerate Cell Therapies To Cure Cancer
Inceptor Bio (“Inceptor”), today announced an agreement with Arranta Bio (“Arranta”) for the acquisition of a 29,000 ft2 process development and GMP clinical manufacturing facility and the transfer of a core operating team to establish cell therapy processes and clinical supply for Inceptor Bio’s planned oncology clinical trials.
October 27, 2021
·
3 min read
Bio NC
Inceptor Bio Enters into In-licensing Agreement with University of California, Santa Barbara For CAR-M Platform
Inceptor Bio today announced that it has executed an in-licensing agreement with the University of California, Santa Barbara (UCSB) for an investigational Chimeric Antigen Receptor Macrophage (CAR-M) therapy targeting difficult-to-treat tumors.
December 16, 2021
·
2 min read
1 of 18
Next